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Milk-derived bioactive peptidesidentify the initial binding sites to the bacterial membranes of the antimicrobial
peptide αs2-casein f(183–207) and also to acquire further insight into membrane permeabilization of this
peptide. Furthermore, cell morphology was studied by transmission electron microscopy. In all the
experiments, bovine LFcin was employed as a comparison. Results showed that initial binding sites of αs2-
casein f(183–207) peptide were lipoteichoic acid in Gram-positive bacteria and lipopolysaccharide in Gram-
negative. The peptide was able to permeabilize the outer and inner membranes. Moreover, the αs2-casein
peptide f(183–207) generated pores in the outer membrane of Gram-negative bacteria and in the cell wall of
Gram-positive bacteria. In the Gram-negative bacteria, f(183–207) originated cytoplasm condensation, and in
the Gram-positive bacteria the cytoplasmic content leaked into the extracellular medium. Furthermore, the
experiments of inner and outer membrane permeabilization performed with LFcin-B showed that this
peptide also has the ability to permeabilize both the inner and outer membranes.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionAntimicrobial peptides appear abundantly throughout all living
nature and presumably form a cornerstone of innate and adaptive
immunity [1]. Despite the chemical and structural heterogeneitywithin
the group of antimicrobial peptides, a few common features can be
distinguished. Most antimicrobial peptides contain a positively charged
domain and are able to adopt an amphipathic conformation allowing
their presence at hydrophilic/hydrophobic interfaces. These properties
are supposed to be essential for antimicrobial activity, the amphipathic
character causing disruption of the negatively charged microbial
membrane leading to cell death [2]. Antimicrobial peptides could, also,
have intracellular targets such as DNA, RNA or proteins [3], inhibition of
macromolecular synthesis [4] and inhibition of bacterial enzymes [5].
The antimicrobial properties of milk have been widely acknowl-
edged for many years. Nowadays, the antimicrobial activity of milk is
mainly attributed to immunoglobulins, and to non-immune proteins,
such as lactoferrin, lactoperoxidase and lysozyme [6]. Interestingly,
over the past 20 years, it has been shown that food proteins can also
act as antimicrobial peptide precursors, and in this way, might
enhance the organism's natural defences against invading patho-
gens. Consequently, food proteins can be considered as components
of nutritional immunity [7,8]. Two of the most potent antibacterial
peptides derived from milk proteins to date are bovine lactoferricin4 91 5644853.
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ll rights reserved.(LFcin), which was released by gastric pepsin cleavage of bovine
lactoferrin and bovine αs2-casein f(183–207) [9]. The antibacterial
domain of bovine LFcin corresponds to bovine lactoferrin f(17–41)
[10]. Lactoferricin has revealed a broad spectrum of activity against
Gram-positive and Gram-negative bacteria [11], fungi [12] and
parasites [13]. Furthermore, lactoferricin has been shown to have
antiviral [14], antitumoral [15,16] and anti-inﬂammatory properties
[17]. Regarding themode of action of bovine LFcin, it is recognized that
the antibacterial activity of LFcin starts by electrostatic interactionwith
the negatively charged membranes of the bacteria [18]. In this initial
binding, lipopolysaccharide and teichoic acid have been identiﬁed as
binding sites in Gram-negative and Gram-positive bacteria, respec-
tively [19]. However, lactoferricin does not lyse susceptible bacteria but
is able to translocate across the cytoplasmic membrane of both Gram-
positive and Gram-negative bacteria [20]. It has been demonstrated
that once the peptide reaches the cytoplasm, bacterial protein
synthesis is inhibited, although the exactmechanism for this inhibition
of macromolecule biosynthesis is not known [4].
Fragment (183–207) of bovine αs2-casein was identiﬁed together
with the f(164–179) of bovineαs2-casein in a peptic hydrolysate of the
same protein [21]. Both fragments showed important antibacterial
activity against Gram-positive and Gram-negative bacteria with MIC
values ranging from 25 to 100 μM in the case of f(164–179), and from
8–16 μM in f(183–207). Recently, a synergistic effect between the f
(183–207) and lactoferrin against Escherichia coli, Staphylococcus
epidermidis and Listeria monocytogenes was demonstrated [22].
Although the bovine αs2-casein f(183–207) has shown a broad
spectrum of activity against Gram-positive and Gram-negative
bacteria, to date, its mechanism of action remained unknown.
2445I. López-Expósito et al. / Biochimica et Biophysica Acta 1778 (2008) 2444–2449The aim of this work was to elucidate the primary binding sites of
the antimicrobial peptideαs2-casein f(183–207) and to investigate the
permeabilizing capacity of this peptide and Lfcin-B.
2. Material and methods
2.1. Bacterial strains
E. coli ATCC 25922 was from the American Type Culture Collection
(ATCC) (Rockville, MD, USA) and Staphylococcus carnosus CECT 4491T
was from The Spanish Type Culture Collection (Colección Española de
Cultivos Tipo, CECT; Valencia, Spain). E. coli ML-35p was kindly
donated by Dr. Lehrer (UCLA School of Medicine, Los Angeles, USA).
E. coli ML-35p was constitutive for a cytoplasmic β-galactosidase,
lacked lactose permease, and expressed a plasmic-encoded periplas-
mic β-lactamase [23]. E. coli ML-35p was maintained on lactose
broth agar plates (Fluka, Buschs, Germany) containing 100 mg/mL of
ampicillin (Sigma, St. Louis, MO, USA). The rest of the bacteria were
maintained on trypticase soy agar plates (Scharlau, Barcelona,
Spain). To obtain organisms for experiments, 10 mL of trypticase soy
broth, or lactose broth containing 100 mg/mL of ampicillin were
inoculated with bacteria from a single colony. After overnight
incubation at 37 °C, the culture was washed three times with
10 mM sodium phosphate buffer, pH 7.4 as previously described
[24], and resuspended in this buffer to the concentration of bacteria
required for each experiment.
2.2. Material and peptides
Lactoferricin-B was prepared by using cation exchange chromato-
graphy and a second step of reversed phase HPLC as previously
described [25]. The primary sequence of the puriﬁed peptide as
determined by HPLC-mass spectrometry and HPLC-tandem
mass spectrometry was: FKC⁎ RRWQWRMKKLGAPSITC⁎VRRAF, with
a disulﬁde bond between cysteine residues (marked with an asterisk).
Bovine αs2-casein f(183–207) (VYQHQKAMKPWIQPKTKVIPYVRYL)
was chemically synthesized by conventional Fmoc solid-phase
synthesis method with a 431 A peptide synthesiser (Applied
Biosystems Inc. Überlingen, Germany). The peptide was puriﬁed
after synthesis by semi-preparative RP-HPLC with the conditions
described by López-Expósito et al. [24]. Staphylococcal ribitol teichoic
acid (TA) and anti-staphylococcal ribitol TA were from Meridian
Diagnostics, (Cincinnati, OH, USA); staphylococcal lipoteichoic acid
(LTA) and lipopolysacaride (LPS) serotype O55:B5 were from Sigma. 3-
(2,4-dinitrostyryl)-(6R,7R)-7-(2-thienylacetamido)-ceph-3-em-4-car-
boxylic acid (nitroceﬁn) was purchased from Calbiochem (San Diego,
CA, USA). o-nitrophenyl-β-D-galactoside (ONPG) was from Sigma.
2.3. Determination of minimal inhibitory concentrations
Determinations of the minimal inhibitory concentration (MIC) of
αs2-casein f(183–207) and Lfcin-B for bacterial strains were per-
formed according to López-Expósito et al. [22].
2.4. Competition assays
Competition assays consisting in checkerboard dilution tests were
carried out according to Vorland et al. [19] with some modiﬁcations.
The antibacterial activity of lactoferricin-B and αs2-casein f(183–207)
was performed in the presence of increasing concentrations of LPS
when using E. coli as bacterial strain, and in the presence of LTA or TA
when using St. carnosus. LTA and LPS were included in a range
between 0 and 100 μg/mL and the ﬁnal peptide concentrations in the
tray were 0–200 μg/mL. The concentration range of TA in the
microtiter tray was 0–1 μg/mL, 0–100 μg/mL for αs2-casein f(183–
207), and 0–50 μg/mL for Lfcin-B. The bacterial inoculum was 1×106bacteria/mL, except in the competition assay with TA, where a
bacterial inoculum of 1×104 was used.
2.5. Blocking experiments with antibodies against TA
These assays were performed as previously described [19]. To
100 μL of 10 mM Na-phosphate buffer pH 7.4 with 2% of TSB, 50 μL of
St. carnosus at a concentration of 1×104 bacteria/mL were added. After
that, 50 μL of anti-TA in a concentration range from 1:1000–1:106
were added and the mixture was incubated at room temperature
during 30 min. Later on, αs2-casein f(183–207) or Lfcin-B were added
at concentrations in the range of 0–250 μg/mL and 0–30 μg/mL
respectively. Themixtures were incubated during 2 h at 37 °C and then
plated on TSA. The plates were incubated at 37 °C 24 h before the
colonies were counted. The assays were conducted in duplicate.
2.6. Concurrent assessment of inner and outer membrane
permeabilization//Nitroceﬁn outer cell barrier permeabilization assay
and inner membrane permeabilization assay
Permeabilization of the inner membrane was assessed by measur-
ing the access of ONPG to the cytoplasm, essentially as described
previously [23] using E. coliML-35p cells prepared as described above.
Concentration of cells in 10 mM phosphate buffer with 100 mM NaCl
was 1×106 bacteria/mL. Brieﬂy, 10 μL of 30 mM ONPG were added to
200 μL of bacteria. After that, 10 μL of the test substance dissolved in
NaCl at a higher concentration than MIC was added. Standard
microplates (Bibby Sterilin, Staffs, UK) were incubated at 37 °C, and o-
nitrophenol productionwasmonitored at 414 nm during 100minwith
a spectrophotometer/ﬂuorometer FLUOstar OPTIMA (BMG Labtech).
Outer membrane permeabilization was measured by the Angus
method with some modiﬁcations [26]. The assays were performed by
using the chromogenic cephalosporin nitroceﬁn. Brieﬂy, 20 μL of the
test substancewere added to 200 μL of E. coliML-35p cells prepared as
described above. After that, 20 μL of nitroceﬁn were added to a ﬁnal
concentration of 40 μM. Standard microplates (Bibby Sterilin) were
incubated at 37 °C, and nitroceﬁn cleavage by β-lactamase was
monitored at 490 nm during 100 min with a spectrophotometer/
ﬂuorometer FLUOstar OPTIMA (BMG Labtech).
2.7. Transmission electron microscopy (TEM)
Cultures of St. carnosus CECT 4491T and E. coli ATCC 25922 at a
concentration of 1×108 bacteria/mL were incubated during 2 h at
37 °C with αs2-casein f(183–207) and lactoferricin-B at a concentra-
tion of 100 μg/mL for all the samples, except for E. coli ATCC 25922
where αs2-casein f(183–207) concentration was 1 mg/mL. The pellet
obtained after centrifugation was resuspended in 0.05 M cacodylate
buffer containing 2% of glutaraldehyde (SERVA, Heidelberg, Germany)
and 4% para-formaldehyde (Merck, Darmstadt, Germany). After 1.5 h
of incubation at room temperature with shaking, three washes with
0.05 M cacodylate buffer were performed. The pellet was ﬁxed with
1% osmium tetroxide and 1% potassium ferrocyanide during 1 h at 4 °C
and treated with 2% uranyl acetate during 1 h before the dehydration
in an ethanol series, and embedded in epoxy resin (TAAB, Bershire,
UK). Finally, the pellet was sectioned, and examined in a JEM1010
(Jeol, Tokio, Japan) TEM. Microphotographs were taken with a digital
camera Bioscan 792 (Gatan Inc, Pleasanton, USA).
3. Results and discussion
3.1. Identiﬁcation of the initial binding sites of αs2-casein f(183–207)
to bacterial membranes
The initial binding step of the peptides to the bacteria is usually the
interaction of positively charged peptides with negatively charged
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bacteria these structures are the LPS. In Gram-positive bacteria, the initial
binding structures are not known, but are assumed to be LTA and TA.
The competition assay between soluble LPS and αs2-casein f(183–
207) against E. coli showed that with increasing amounts of LPS, an
increasing concentration of the peptide was needed to achieve a
growth inhibitory effect (Fig. 1a). Lactoferricin-B showed a similar
behavior to that revealed by the αs2-casein peptide (Fig. 1a), which
was previously described by Vorland et al. [19]. Results obtained
revealed that LPS could be an initial binding site for both the αs2-
casein and LFcin-B in E. coli ATCC 25922.
When using LTA and αs2-casein f(183–207) or LFcin-B against St.
carnosus in the competition assay, it was observed that, as in
experiments performed with LPS, with increasing amounts of LTA,
an increasing concentration of the peptides was needed to achieve a
growth inhibitory effect (Fig. 1b). It was found that the same amount
of LTA compared to the amount of peptide (in weight) was necessary
to abolish the effect of f(183–207) from bovine αs2-casein. If the
molecular mass of LTA is approximately twice the molecular mass of
fragment 183–207, then 1 molecule of LTA binds 2 molecules of
peptide. For LFcin-B, the ratio found was 1 molecule of LTA binding 1
molecule of LFcin-B. Therefore, LTA could be an initial binding site for
both the αs2-casein f(183–207) and LFcin-B in St. carnosus. In the
absence of free LTA, both peptides have a similar MIC value against St.
carnosus, but the addition of LTA had more effect on the activity of the
αs2-casein peptide than on the activity of LFcin-B.
The TA possessed antimicrobial activity towards St. carnosus and
this made the competition assay difﬁcult to perform. Because of this,
lower concentrations of TA and bacterial inoculum were employed to
reduce the concentration of TA used in the assay. Results obtained did
not reveal MIC variations for both peptides when assayed together
with TA.
Due to this antibacterial effect of TA, interaction of these peptides
with TA was performed by blocking experiments with antibodiesFig. 1. (a) Inﬂuence of the concentration of soluble lipopolysaccharide upon the MIC of
bovineαs2-casein f(183–207) (R2=0.91) (▪) and LFcin-B (R2=0.98) (O) against E. coli. (b)Inﬂuence of the concentration of soluble lipoteichoic acid upon the MIC of bovine αs2-
casein f(183–207) (R2=0.93) (▪) and LFcin-B (R2=0.99) (O) against St. carnosus.against TA. Results conﬁrmed that TAwas not an initial binding site for
αs2-casein f(183–207) in St. carnosus because, when the concentration
of Anti-TA was increased, MIC remained invariable. On the contrary,
when LFcin-B was assayed with anti-TA, an increase in the MIC
together with the increase in anti-TA concentration was achieved,
revealing that TA plays a role as the initial binding site for LFcin-B in St.
carnosus (data not shown).
3.2. Concurrent assessment of inner and outer
membrane permeabilization
To test the ability of αs2-casein f(183–207) and LFcin-B to
permeabilize the E. coli ML-35p outer and inner membranes, two
chromogenic reporter molecule systems were used at the same time.
Permeabilization of the outer membrane was monitored using
nitroceﬁn as a probe. Nitroceﬁn is normally excluded by the outer
cell membrane, but if able to pass this barrier it can be cleaved by β-
lactamase localized within the periplasmic space. Cleavage results in
a color change from yellow to red, and this can be used to monitor
outer membrane permeabilization. In a similar way, permeabilization
of the inner membrane was monitored using the β-galactosidase
substrate ONPG as a probe. In E. coli strain ML-35p that lacks lactose
permease, ONPG is blocked from cell entry by the inner membrane,
but if able to pass this barrier ONPG can be cleaved by β-galactosidase
localized within the cytoplasm, which results in the appearance of
a yellow color. With these two reporter systems, it is possible to
monitor permeabilization of both the outer and inner E. coli
membranes [27].
Fig. 2a and b show the results related to the outer membrane
permeabilization assays of αs2-casein f(183–207) and LFcin-B,
respectively. Firstly, outer membrane permeabilization was estab-
lished in the absence of peptides, obtaining in both cases a practically
constant curve with absorbance at 492 nm values around 0.4. When
the peptide concentration was increased, a dose-dependent increase
in absorbance was achieved demonstrating for both peptides their
capacity to permeabilize the outer membrane. The capacity to
permeabilize the outer membrane reached its peak when the
concentration used for both peptides was 25 μg/mL. These results
complement those published by Chapple et al. [28] who observed
blister formation in the outer membrane of E. coli when assayed with
LFcin-B. It is likely that outer membrane permeabilization produced a
membrane depolarization that leads to formation of the blisters [29].
Although Ulvatne et al. [4] postulated a possible mechanism of action
for the lactoferrin-derived peptide, experiments to study the stability
of the inner and outer membranes have not yet been performed.
Fig. 2c and d show the results obtained when E. coli ML-35p was
exposed to αs2-casein f(183–207) (Fig. 2c) and LFcin-B (Fig. 2d) to
evaluate innermembrane permeabilization. In the conditions assayed,
ONPG hydrolysis occurred at lower doses for LFcin-B than for αs2-
casein f(183–207). ONPG hydrolysis occurred at the lowest concen-
tration of LFcin-B (62.5 μg/ml), while for αs2-casein f(183–207) a
signiﬁcant hydrolysis of this probe was only observed at 500 μg/ml
and 2000 μg/ml. Since the ﬂuorescence rapidly increased in
comparison to the control (even at time zero absorbance is increased
with increasing concentration of peptide), it is probable that the main
change of the innermembrane occurred at an early time. This was also
observed by Niidome et al. [30] who described the capacity to
permeabilize the inner membrane of the antimicrobial peptide
Maculatin 1.1. Results obtained with LFcin-B could be a relevant
advance in the study of the action mechanism of this peptide. The
increased rate of nitroceﬁn or ONPG conversion could also be
attributed to β-lactamase or β-galactosidase escaped from cells rather
than to probe entry. However, this seems unlikely because the
enzymes are much larger than the chromogenic probes and
permeabilizing peptides used here. Furthermore, neither β-lactamase
nor β-galactosidase leakage in the presence of cell-permeabilizing
Fig. 3. TEMmicrographs taken of E. coli ATCC 25922. (a) and (b) cells untreated. The arrow in panel b indicates the periplasmic space. (c) and (d) cells treated with bovineαs2-casein f
(183–207) at a concentration of 31 μM during 2 h at 37 °C. Arrows in panel (d) indicate the loss of continuity of the membrane and the swollen area between inner and outer
membrane. (e) and (f) cells treated with LFcin-B at a concentration of 31 μM during 2 h at 37 °C. The arrow in panel e indicates a blister in the outer membrane.
Fig. 2. Concurrent measurements of E. coli ML-35p outer and inner membrane permeabilization. (a) kinetics of nitroceﬁn passage across the outer membrane in presence of αs2-
casein f(183–207) and (b) LFcin-B. The symbols represented different concentrations of peptide (O) Control, (▪) 500 μg/mL, (▲) 250 μg/mL, (×) 125 μg/mL y (*) 25 μg/mL, (●) 2,5 μg/mL, (|) 0.25 μg/mL. (c) kinetics of ONPG passage across the inner membrane in presence ofαs2-casein f(183–207) and (d) LFcin-B. The symbols represented different concentrations of
peptide (O) Control, (●) 2000 μg/mL (▪) 500 μg/mL, (▲) 250 μg/mL, (×) 125 μg/mL and (*) 62.5 μg/mL.
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here [27]. Since the results showed that αs2-casein f(183–207) and
LFcin-B were indeed membrane permeabilizer peptides, cell entry is
thus a limiting factor for peptide potency. Concurrent monitoring of
outer and inner membrane permeabilization indicated that peptide
activity at the inner membrane closely followed that of the outer
membrane, showing that it is predominantly the outer membrane
that limits peptide entry.
3.3. Transmission electron microscopy (TEM)
With the aim of evaluating the morphological changes in Gram-
positive and Gram-negative bacteria after incubationwithαs2-casein f
(183–207) and LFcin-B, TEM studies were performed. E. coli ATCC
25922 and St. carnosus cells were incubated for 2 h at 37 °C in the
presence and absence of the above-mentioned peptides at a
concentration of 31 μM. Upon incubation, cells were ﬁxed and cut
into sections to be observed by TEM.
Figs. 3a, b, 4a and b show the microphotographs corresponding to
intact cells of E. coli ATCC 25922 (Fig. 3a, b) and St. carnosus (Fig. 4a, b).
As it is shown, the cytoplasmic content was evenly distributed and
ﬁlled the whole space encapsulated by the bacterial wall. In E. coli
ATCC 25922 the outer and inner membranes of the bacterial envelope
were smooth and ran in parallel separated by a thin distinct
periplasmic space indicated by an arrow (Fig 3b). Microphotographs
obtained in absence of the peptides did not show cell aggregation in
either microorganism.
Fig. 3c and d show the results obtained when E. coli ATCC 25922
cells were incubated with bovineαs2-casein f(183–207). A remarkable
damage in the bacteria outer membrane was achieved with a loss in
continuity (Fig 3d). Furthermore, the inner membrane appeared
distended and displaced in relation to the cytoplasmic membrane (Fig
3d). The swollen area between these two membranes may be caused
by the intake of water from the medium into the cell. Incubation withFig. 4. TEM micrographs taken of St. carnosus. (a) and (b): cells untreated. (c) and (d) cells tre
Arrow in panel (c) indicates a blister in the outer membrane. (e) and (f) cells treated with Lthe αs2-casein peptide also promoted cytoplasm condensation in
almost 100% of cells (Fig. 3c) and in many cases leakage of the
cytoplasm content (Fig. 3c).
The images obtained when bovine αs2-casein f(183–207) was
incubated with St. carnosus were greatly different to those of
untreated cells. A great number of cells appeared with their cell
walls missing and the cytoplasmic content leaked to the extracellular
medium (Fig. 4d). Furthermore, formation of blisters in the bacterial
wall was detected (Fig. 4c). These blisters could represent the results
of the interaction between theαs2-casein derived peptide and LTA and
the subsequent membrane destabilization.
From the results obtained it can be postulated that the αs2-casein
derived peptide would be able to interact initially with the negatively
charged LPS molecules in Gram-negative microorganisms and with
LTA molecules in the Gram-positive ones. When the outer membrane
was reached, a destabilization and breakage could be produced by
charge neutralization as in the model proposed by Hancock and
Chapple [31]. This model implies transit across the inner membrane
under the inﬂuence of a transmembrane electrical potential gradient
or by the formation of micelle-like aggregates, and therefore further
experiments are necessary to support this hypothesis. The results
obtained assessed the permeabilization of the inner membrane. If the
peptide passes through the inner membrane, this could produce an
imbalance of osmotic forces between the inner and outer membranes.
The imbalance might cause cytoplasm content to leak from the cell
causing distortion and shrinkage as described when Klebsiella
pneumoniae cells were incubated with cecropins [32].
Fig. 3e and f show the results obtained when E. coli ATCC 25922
was incubated with LFcin-B for 2 h. The bacterial morphology is
completely different to that of the control and also different to the
morphology observed when cells were incubated with the αs2-casein
derived peptide, whichmay imply a different action mechanism. After
incubationwith LFcin-B the cell shape was signiﬁcantly modiﬁed with
lengthening of the membranes and condensed cytoplasm elements inated with bovine αs2-casein f(183–207) at a concentration of 31 μM during 2 h at 37 °C.
Fcin-B at a concentration of 31 μM during 2 h at 37 °C.
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addition, irregular shaped areas with a larger periplasmic space and
the appearance of membrane blisters was observed (Fig. 3e).
Interestingly, the bacterial membrane was not visibly damaged, thus
pore formation is improbable. The results obtained agreed with those
reported by Ulvatne et al. [29] which demonstrated that LFcin-B did
not produce bacterial lysis as a result of pore formation.
Fig. 4e and f showed the images obtained after incubate St.
carnosuswith 31 μM LFcin-B. Contrary to the results obtained after the
incubation with E. coli, a high percentage of cell aggregation was
detected. The microphotographs also showed a practically disinte-
grated membrane (Fig. 4e).
The results obtained agree with the observations reported in
relation to the action mechanism of LFcin-B [34]. The mechanism of
action proposed by Ulvatne et al. [4] found that the initial interaction
between LFcin-B and bacteria is mediated through interactions with
LPS and TA. This agrees with the previously described results aimed at
identifying the initial binding site for LFcin-B. As a result of these
interactions, a disruption in the outer membrane of Gram-negative
bacteria could take place leading to the formation of blisters at the
interaction sites (Fig. 3f). The resulting organization of the structure of
the outermembrane could enable the tryptophan residues to approach
the lipid-A from the peptidoglican for hydrophobic interactions,
leading to further penetration of the outer membrane [35]. This
process could be responsible for the positive results obtained in the
outer membrane permeabilization assays. At this point it has been
postulated that the initial interaction between the bacteria and LFcin-B
may evoke an SOS-like response [4]. Once the peptide reaches the
cytoplasm, bacterial protein synthesis is inhibited by an undetermined
mechanism, an event that eventually leads to death of the bacterial cell.
In conclusion, results showed that initial binding sites of the αs2-
casein f(183–207) peptide were lipoteichoic acid in Gram-positive
bacteria and lipolysaccharide in Gram-negative bacteria and that the
peptide is able to permeabilize the outer and inner membranes.
Moreover, the αs2-casein peptide f(183–207) generated pores in the
outer membrane of Gram-negative bacteria and in the cell wall of
Gram-positive bacteria. In the Gram-negative bacteria, f(183–207)
originated the cytoplasm condensation, and in the Gram-positive
bacteria the cytoplasmic content leaked into the extracellular
medium. Furthermore, the experiments of inner and outer membrane
permeabilization performed with LFcin-B add new insights in the
study of its action mechanism. Although the capacity of LFcin-B to
reach the cytoplasmwas known previously, there were no data about
the capacity of LFcin-B to permeabilize both the inner and outer
membranes.
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